225 related articles for article (PubMed ID: 29845255)
21. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
[TBL] [Abstract][Full Text] [Related]
22. The roles of miR-200c in colon cancer and associated molecular mechanisms.
Chen J; Wang W; Zhang Y; Hu T; Chen Y
Tumour Biol; 2014 Jul; 35(7):6475-83. PubMed ID: 24682933
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer.
Park YR; Lee ST; Kim SL; Liu YC; Lee MR; Shin JH; Seo SY; Kim SH; Kim IH; Lee SO; Kim SW
Int J Oncol; 2016 May; 48(5):2135-43. PubMed ID: 26983891
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of miR-720 prognostic significance in patients with colorectal cancer.
Wang X; Kuang Y; Shen X; Zhou H; Chen Y; Han Y; Yuan B; Zhou J; Zhao H; Zhi Q; Xue X
Tumour Biol; 2015 Feb; 36(2):719-27. PubMed ID: 25286763
[TBL] [Abstract][Full Text] [Related]
25. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
Fang Y; Sun B; Wang J; Wang Y
Gene; 2019 May; 699():37-42. PubMed ID: 30851425
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.
Li J; Chen Y; Guo X; Zhou L; Jia Z; Tang Y; Lin L; Liu W; Ren C
Tumour Biol; 2016 Jul; 37(7):8765-73. PubMed ID: 26743779
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1.
Xu X; Chen R; Li Z; Huang N; Wu X; Li S; Li Y; Wu S
BMC Cancer; 2015 Dec; 15():1023. PubMed ID: 26714817
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
29. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract][Full Text] [Related]
31. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
[TBL] [Abstract][Full Text] [Related]
33. microRNA-497 inhibits invasion and metastasis of colorectal cancer cells by targeting vascular endothelial growth factor-A.
Qiu Y; Yu H; Shi X; Xu K; Tang Q; Liang B; Hu S; Bao Y; Xu J; Cai J; Peng W; Cao Q; Yin P
Cell Prolif; 2016 Feb; 49(1):69-78. PubMed ID: 26840372
[TBL] [Abstract][Full Text] [Related]
34. GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal Cancer.
Mielcarska S; Stopińska K; Dawidowicz M; Kula A; Kiczmer P; Seńkowska AP; Zajdel EN; Walkiewicz K; Waniczek D; Świętochowska E
Curr Med Sci; 2021 Jun; 41(3):522-528. PubMed ID: 34169422
[TBL] [Abstract][Full Text] [Related]
35. MiR-382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer.
Zhou B; Song J; Han T; Huang M; Jiang H; Qiao H; Shi J; Wang Y
Mol Carcinog; 2016 Dec; 55(12):2260-2267. PubMed ID: 26800338
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
Yin Y; Yan ZP; Lu NN; Xu Q; He J; Qian X; Yu J; Guan X; Jiang BH; Liu LZ
Biochim Biophys Acta; 2013 Feb; 1829(2):239-47. PubMed ID: 23201159
[TBL] [Abstract][Full Text] [Related]
37. ITGBL1 promotes migration, invasion and predicts a poor prognosis in colorectal cancer.
Qiu X; Feng JR; Qiu J; Liu L; Xie Y; Zhang YP; Liu J; Zhao Q
Biomed Pharmacother; 2018 Aug; 104():172-180. PubMed ID: 29772438
[TBL] [Abstract][Full Text] [Related]
38. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
39. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of circadian gene 'hClock' contribution to metastasis of colorectal cancer.
Wang Y; Sun N; Lu C; Bei Y; Qian R; Hua L
Int J Oncol; 2017 Jun; 50(6):2191-2199. PubMed ID: 28498393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]